Prime Medicine

PRME · NASDAQ

$3.92+$0.09 (+2.35%)TodayMarket closed ·
Prev close $3.83

Latest news

  • NewsAvi Kapoor

    Humana, Evolution Metals & Technologies, Fastly And Other Big Stocks Moving Higher On Friday

  • NewsAvi Kapoor

    Apogee Enterprises Posts Upbeat Q2 Earnings, Joins Constellation Energy, Freshworks And Other Big Stocks Moving Higher On Tuesday

  • Press releaseGlobe Newswire

    Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease

  • NewsVandana Singh

    Prime Medicine Gets FDA Green Light for Gene Editing Study

  • NewsAvi Kapoor

    Why INLIF Shares Are Trading Higher By Around 78%; Here Are 20 Stocks Moving Premarket

  • NewsAvi Kapoor

    Costco Wholesale, Scholastic and 3 Stocks to Watch Heading Into Friday

  • News

    FDA Clears Prime Medicine’s IND Application For PM647, Investigational In Vivo Prime Editor For Alpha-1 Antitrypsin Deficiency

  • Press releaseGlobe Newswire

    Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency

  • Press releaseGlobe Newswire

    Prime Medicine to Participate in Upcoming Investor Conferences

  • Press releaseGlobe Newswire

    Prime Medicine Reports Second Quarter 2026 Financial Results and Provides Business Updates

  • Press releaseGlobe Newswire

    Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM577a in H1069Q-mutated Wilson Disease

  • NewsVandana Singh

    Prime Medicine Secures Favorable Arbitration Ruling in Beam Therapeutics Case

  • NewsAvi Kapoor

    Penguin Solutions, Beazer Homes, Alibaba And Other Big Stocks Moving Higher On Wednesday

  • Press releaseGlobe Newswire

    Prime Medicine Announces Positive Resolution to Arbitration with Beam Therapeutics

  • Press releaseGlobe Newswire

    Prime Medicine Receives U.S. FDA Regenerative Medicine Advanced Therapy (RMAT) Designation for PM359 for the Treatment of Chronic Granulomatous Disease (CGD)

  • Press releaseGlobe Newswire

    Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease

  • Press releaseGlobe Newswire

    Prime Medicine to Present at Goldman Sachs 47th Annual Global Healthcare Conference

  • Press releaseGlobe Newswire

    Prime Medicine to Present at Jefferies Global Healthcare Conference

  • NewsAvi Kapoor

    Abercrombie & Fitch Upbeat Q1 Earnings, Joins Digital Turbine, Dycom Industries And Other Big Stocks Moving Higher On Wednesday

  • Press releasePRNewswire

    The $578 Billion Regenerative Medicine Market Has a Manufacturing Problem. One Company Just Solved the First Step

  • Press releasePRNewswire

    Advanced Cell-based Therapy Booming the Success for Healthcare Sector

  • News

    Prime Medicine Option Alert: Mar 20 $4 Calls Sweep (5) near the Ask: 2055 @ $0.4 vs 2056 OI; Earnings 3/10 Before Open [est] Ref=$4.03

  • Press releaseGlobe Newswire

    Prime Medicine to Participate in Upcoming Investor Conferences

  • Press releaseGlobe Newswire

    Prime Medicine to Present at 44th Annual J.P. Morgan Healthcare Conference

  • Press releasePRNewswire

    Gene Therapy: 5 Biotech Stocks Chasing the $36B Prize

  • Press releaseGlobe Newswire

    Prime Medicine to Present at 8th Annual Evercore Healthcare Conference

  • Press releaseGlobe Newswire

    Prime Medicine to Present at Jefferies Global Healthcare Conference

  • Press releaseGlobe Newswire

    Prime Medicine to Host Virtual KOL Event to Showcase Wilson's Disease Strategy

  • Press releaseGlobe Newswire

    Prime Medicine to Participate in Upcoming Investor Conferences

  • NewsAvi Kapoor

    Macy's Increases FY2025 Outlook, Joins REV Group, HealthEquity, Alphabet and Wellness And Other Big Stocks Moving Higher On Wednesday

  • Press releaseGlobe Newswire

    Prime Medicine to Participate in Upcoming Investor Conferences

  • NewsAvi Kapoor

    Align Technology Posts Downbeat Earnings, Joins Confluent,FormFactor And Other Big Stocks Moving Lower In Thursday Pre-Market Session

  • News

    12 Health Care Stocks Moving In Thursday's Pre-Market Session

  • NewsAvi Kapoor

    Why Meta Platforms Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket

  • News

    12 Health Care Stocks Moving In Wednesday's After-Market Session

  • NewsAvi Kapoor

    KalVista Pharmaceuticals, Cogent Biosciences, WNS And Other Big Stocks Moving Higher On Monday

  • News

    10 Health Care Stocks With Whale Alerts In Today's Session

  • NewsAvi Kapoor

    Hut 8, Greenbrier And Other Big Stocks Moving Higher On Tuesday

  • Press releaseGlobe Newswire

    Prime Medicine to Participate in Upcoming Investor Conferences

  • NewsAvi Kapoor

    This MongoDB Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Tuesday

  • News

    6 Analysts Assess Prime Medicine: What You Need To Know

  • NewsRounak Jain

    Cathie Wood's Ark Invest Offloads UiPath, Prime Medicine, And Repare Therapeutics

  • Press releaseGlobe Newswire

    Prime Medicine to Present at TD Cowen 45th Annual Health Care Conference

  • Press releasePRNewswire

    Kuehn Law Encourages Investors of Prime Medicine, Inc. to Contact Law Firm

  • Press releaseGlobe Newswire

    Prime Medicine to Present at 43rd Annual J.P. Morgan Healthcare Conference

  • Press releaseGlobe Newswire

    Prime Medicine to Participate in Upcoming Investor Conferences

  • NewsAvi Kapoor

    Dow Dips 300 Points; Emcore Shares Spike Higher

  • NewsAvi Kapoor

    Crude Oil Moves Higher; Prime Medicine Shares Spike Higher

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.